IQVIA Holdings Inc. (IQV)
NYSE • Healthcare
Last close at October 2, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, IQVIA Holdings Inc. keeps $6 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Oct 27
in 23 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
IQVIA Holdings beat consensus on both the top and bottom line in the fiscal second quarter of 2026, reported July 28, as revenue of roughly $4.4 billion topped the roughly $4.3 billion estimate by about 2% and adjusted EPS of $3.15 beat the $3.03 estimate by about 4%. Revenue rose about 9% to about $4.4 billion from $4.02 billion a year ago, while adjusted EPS was up about 12% from $2.81 and net income fell about 4% to roughly $256 million from $266 million. Gross profit reached about $1.4 billion, leaving gross margin near 33%, and operating income came to about $506 million with operating margin about 12%, the key margin readout for the period. Operating cash flow was about $558 million, and the company repurchased about $398 million of stock, giving the quarter a cash-return component alongside the earnings beat and revenue growth in the quarter. Consensus for the next period calls for EPS of $3.24 on revenue of $4.33 billion.
Next report — what to expect
IQVIA Holdings Inc. (IQV) reports on October 27, 2026. Wall Street is looking for EPS of $3.25 on revenue of $4.36 billion. For trailing context, revenue grew +8.7% year over year last quarter. IQVIA has beaten EPS in 8 of 8 most recent quarters, making EPS delivery a key focus.
About IQVIA Holdings Inc.
IQVIA Holdings Inc. (NYSE: IQV) provides healthcare data, research, and commercialization services, combining technology platforms with contract research and field support for life sciences customers. In FY2025, the company generated $16.3 billion in revenue, and it operates in the medical diagnostics and research side of the healthcare sector.
Today's Snapshot
IQV closed 1% lower at 258.21, while its sector was flat.
Trading Volume
Below 10d avg (1.4M)
1.3M
vs S&P 500 Today
Underperforming Market
-1.74%
Updated: October 2, 2026 at 20:19 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$219.97 - $265.87Buy
- RSI (14)45.29Neutral
- Stochastic %K (14, 3, 3)23.85Neutral
- MACD Level (12, 26)3.40Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.